Quince Therapeutics reported net income of -$75.84M for the quarter ended Jun 2026. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.15M | 0.15M | 0.15M | 0.18M | 0.18M | 0.18M | 0.18M | 0.18M | 0.18M | 0.21M | 0.22M | 0.22M | 0.22M | 0.22M | 0.22M | 0.27M | 0.27M | 0.28M | 0.46M | 6.13M | ||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 14.04M | 15.21M | 12.76M | 2.45M | 7.20M | 3.23M | 1.35M | 1.43M | 3.43M | 3.70M | 4.15M | 4.92M | 5.83M | 8.14M | 6.55M | 8.08M | 12.60M | 6.84M | 5.46M | |||||||||||||||
| Wages, Salaries and OtherWages | 1.57M | 1.16M | 1.07M | 1.73M | 1.04M | 1.10M | 1.16M | 1.56M | 4.98M | |||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 7.64M | 8.33M | 9.11M | 4.34M | 9.01M | 3.83M | 4.23M | 4.66M | 4.91M | 4.97M | 4.70M | 3.63M | 4.28M | 4.79M | 3.34M | 3.28M | 3.63M | 4.27M | 16.63M | |||||||||||||||
| Restructuring CostsRestructuring | 0.97M | 0.85M | 0.77M | 0.65M | 0.68M | 0.64M | 0.66M | 0.63M | -1.30M | |||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.82M | 5.90M | 1.58M | 2.54M | 18.38M | -3.53M | 1.13M | 1.28M | -0.15M | 1.43M | 2.45M | 2.85M | 59.00M | |||||||||||||||||||||
| Operating ExpensesOpex | 21.68M | 23.54M | 21.86M | 7.62M | 16.21M | 12.96M | 5.58M | 6.09M | 9.92M | 11.22M | 28.19M | 5.86M | 12.01M | 14.86M | 10.43M | 13.43M | 19.35M | 14.59M | 79.78M | |||||||||||||||
| Operating IncomeOp. Inc | -21.68M | -23.54M | -21.86M | -16.26M | -7.62M | -6.32M | -12.96M | -5.58M | -6.09M | -9.92M | -11.22M | -28.19M | -5.86M | -12.01M | -14.86M | -10.43M | -13.43M | -19.35M | -14.59M | -79.78M | ||||||||||||||
| EBIT | -21.68M | -23.54M | -21.86M | -16.26M | -7.62M | -6.32M | -12.96M | -5.58M | -6.09M | -9.92M | -11.22M | -28.19M | -5.86M | -12.01M | -14.86M | -10.43M | -13.43M | -19.35M | -14.59M | -79.78M | ||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | ||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.13M | 0.10M | 0.07M | 0.14M | 0.32M | 0.54M | 0.70M | 0.81M | 0.96M | 1.01M | 0.89M | 0.82M | 0.68M | 0.54M | 0.41M | 0.31M | 0.30M | 0.23M | 0.16M | 0.58M | ||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.16M | 0.04M | 0.15M | -0.73M | -0.62M | 0.25M | -0.25M | -0.11M | -0.22M | 0.40M | -0.40M | 0.09M | 0.15M | -0.52M | -0.09M | -0.03M | -0.06M | 18.02M | 1.72M | 1.30M | ||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||
| EBT | -21.71M | 66.55M | -21.64M | -16.85M | -7.92M | -5.53M | -12.50M | -4.89M | -5.35M | -8.84M | -11.12M | -27.69M | -5.48M | -12.45M | -14.98M | -15.98M | -13.49M | -36.31M | 30.57M | -75.41M | ||||||||||||||
| Tax ProvisionsTaxes | -0.28M | -0.25M | 0.05M | 0.03M | 0.04M | 0.01M | 0.05M | 0.05M | 0.07M | -0.05M | -17.03M | -5.34M | 0.10M | |||||||||||||||||||||
| Profit After TaxPAT | -22.48M | -25.03M | -22.07M | -20.66M | -7.92M | -5.54M | -12.25M | -4.89M | -5.35M | 3.70M | -12.37M | -28.47M | -5.49M | -15.54M | -15.03M | -16.05M | -13.44M | -39.46M | 35.91M | -75.84M | ||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -21.71M | 66.55M | -21.64M | -16.56M | -7.92M | -5.53M | -12.25M | -4.89M | -5.35M | -8.89M | -11.15M | -27.73M | -5.49M | -12.50M | -15.03M | -16.05M | -13.44M | -19.28M | 35.91M | -75.51M | ||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -21.71M | 66.55M | -21.64M | -16.56M | -7.92M | -5.53M | -12.25M | -4.89M | -5.35M | -8.89M | -11.15M | -27.73M | -5.49M | -12.50M | -15.03M | -16.05M | -13.44M | -19.28M | 35.91M | -75.51M | ||||||||||||||
| Income towards Parent CompanyParent Net Inc | -21.71M | 66.55M | -21.64M | -16.56M | -7.92M | -5.53M | -12.25M | -4.89M | -5.35M | -8.89M | -11.15M | -27.73M | -5.49M | -12.50M | -15.03M | -16.05M | -13.44M | -19.28M | 35.91M | -75.51M | ||||||||||||||
| Net Income towards Common StockholdersNet Income | -21.71M | 66.55M | -21.64M | -16.56M | -7.92M | -5.53M | -12.25M | -4.89M | -5.35M | -8.89M | -11.15M | -27.73M | -5.49M | -12.50M | -15.03M | -16.05M | -13.44M | -19.28M | 32.79M | -75.49M | ||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| EPS (Basic) | -145.84 | 447.84 | -143.63 | -102.04 | -44.48 | -33.04 | -68.35 | -27.21 | -29.67 | -47.77 | -51.84 | -128.68 | -25.45 | -57.80 | -68.41 | -68.75 | -49.83 | -76.98 | 71.91 | -12.31 | ||||||||||||||
| EPS (Diluted) | -145.84 | 447.84 | -143.63 | -102.04 | -44.48 | -33.04 | -68.35 | -27.21 | -29.67 | -47.77 | -51.84 | -128.68 | -25.45 | -57.80 | -68.41 | -68.75 | -49.83 | -76.98 | 71.37 | -12.31 | ||||||||||||||
| Shares Outstanding | 0.15M | 0.15M | 0.15M | 0.16M | 0.18M | 0.17M | 0.18M | 0.18M | 0.18M | 0.19M | 0.22M | 0.22M | 0.22M | 0.22M | 0.22M | 0.23M | 0.27M | 0.25M | 0.46M | 6.13M | ||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.15M | 0.15M | 0.15M | 0.16M | 0.18M | 0.17M | 0.18M | 0.18M | 0.18M | 0.19M | 0.22M | 0.22M | 0.22M | 0.22M | 0.22M | 0.23M | 0.27M | 0.25M | 0.46M | 6.13M | ||||||||||||||
| EBITDA | -21.68M | -23.54M | -21.86M | -16.26M | -7.62M | -6.32M | -12.96M | -5.58M | -6.09M | -9.92M | -11.22M | -28.19M | -5.86M | -12.01M | -14.86M | -10.43M | -13.43M | -19.35M | -14.59M | -79.78M | ||||||||||||||
| Interest ExpensesInt Expense | ||||||||||||||||||||||||||||||||||
| Tax Rate | 1.69 | 1.98 | -0.58 | -0.28 | -0.13 | -0.24 | -0.42 | -0.31 | -0.42 | 0.34 | 46.90 | -17.46 | -0.13 |